• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美加明增加尼古丁偏好并减弱尼古丁辨别能力。

Mecamylamine increases nicotine preference and attenuates nicotine discrimination.

作者信息

Rose J E, Sampson A, Levin E D, Henningfield J E

机构信息

VA Medical Center, Durham, NC 27705.

出版信息

Pharmacol Biochem Behav. 1989 Apr;32(4):933-8. doi: 10.1016/0091-3057(89)90061-0.

DOI:10.1016/0091-3057(89)90061-0
PMID:2798542
Abstract

Eight subjects evaluated various qualities of cigarette smoke after being given a range of doses (0, 2.5, 10 and 20 mg) of the nicotinic receptor blocker mecamylamine. In one test condition, subjects were given either high or low nicotine tobacco smoke to determine the effects of mecamylamine on their subjective responses. In another test condition, subjects were allowed to adjust the nicotine dose level of the smoke to determine the effects of mecamylamine on dose preference. When the subjects evaluated puffs of smoke with high and low nicotine content, mecamylamine caused a dose-related decrease in the self-rated strength and harshness of the high nicotine dose level smoke. In contrast, there was little effect on the low dose smoke. At the highest mecamylamine dose (20 mg) there was no significant difference in the ratings of high and low nicotine cigarettes. Low doses of mecamylamine decreased the reported desire for a cigarette, and also attenuated the reduction in desire for a cigarette caused by smoking. When the subjects were allowed to select their preferred level of nicotine intake using a smoke mixing device, the 10 and 20 mg doses of mecamylamine caused a significant increase in self-administered nicotine dose level. Despite this compensatory increase in nicotine self-administration, the reduction in desire for a cigarette after smoking was still less than after placebo.

摘要

八名受试者在服用一系列剂量(0、2.5、10和20毫克)的烟碱受体阻滞剂美加明后,对香烟烟雾的各种特性进行了评估。在一种测试条件下,受试者被给予高尼古丁或低尼古丁烟草烟雾,以确定美加明对其主观反应的影响。在另一种测试条件下,受试者被允许调整烟雾中的尼古丁剂量水平,以确定美加明对剂量偏好的影响。当受试者评估高尼古丁含量和低尼古丁含量的烟雾抽吸时,美加明导致高尼古丁剂量水平烟雾的自我评定强度和刺激性出现剂量相关的降低。相比之下,对低剂量烟雾几乎没有影响。在美加明的最高剂量(20毫克)下,高尼古丁香烟和低尼古丁香烟的评分没有显著差异。低剂量的美加明降低了报告的吸烟欲望,也减弱了吸烟导致的吸烟欲望降低。当受试者使用烟雾混合装置选择他们偏好的尼古丁摄入量水平时,10毫克和20毫克剂量的美加明导致自我给药的尼古丁剂量水平显著增加。尽管尼古丁自我给药有这种代偿性增加,但吸烟后对香烟的欲望降低仍低于服用安慰剂后。

相似文献

1
Mecamylamine increases nicotine preference and attenuates nicotine discrimination.美加明增加尼古丁偏好并减弱尼古丁辨别能力。
Pharmacol Biochem Behav. 1989 Apr;32(4):933-8. doi: 10.1016/0091-3057(89)90061-0.
2
Acute effects of nicotine and mecamylamine on tobacco withdrawal symptoms, cigarette reward and ad lib smoking.尼古丁和美加明对烟草戒断症状、香烟奖赏及随意吸烟的急性影响。
Pharmacol Biochem Behav. 2001 Feb;68(2):187-97. doi: 10.1016/s0091-3057(00)00465-2.
3
Mecamylamine acutely increases human intravenous nicotine self-administration.美加明急性增加人类静脉注射尼古丁自我给药量。
Pharmacol Biochem Behav. 2003 Sep;76(2):307-13. doi: 10.1016/j.pbb.2003.08.011.
4
Mecamylamine blockade of both positive and negative effects of IV nicotine in human volunteers.
Pharmacol Biochem Behav. 2000 Jul;66(3):637-43. doi: 10.1016/s0091-3057(00)00252-5.
5
Effects of central and peripheral nicotinic blockade on human nicotine discrimination.中枢和外周烟碱阻断对人体尼古丁辨别能力的影响。
Psychopharmacology (Berl). 1999 Feb;142(2):158-64. doi: 10.1007/s002130050875.
6
Effects of mecamylamine on human cigarette smoking and subjective ratings.美加明对人类吸烟及主观评分的影响。
Psychopharmacology (Berl). 1986;88(4):420-5. doi: 10.1007/BF00178502.
7
Effects of stimulation or blockade of central nicotinic-cholinergic receptors on performance of a novel version of the rat stimulus discrimination task.
Psychopharmacology (Berl). 1996 Jan;123(2):172-81. doi: 10.1007/BF02246174.
8
Mecamylamine pretreatment increases subsequent nicotine self-administration as indicated by changes in plasma nicotine level.如血浆尼古丁水平的变化所示,美加明预处理会增加随后的尼古丁自我给药量。
Psychopharmacology (Berl). 1987;91(3):391-3. doi: 10.1007/BF00518198.
9
Discriminability of nicotine in tobacco smoke: implications for titration.烟草烟雾中尼古丁的可辨别性:对滴定的影响。
Addict Behav. 1984;9(2):189-93. doi: 10.1016/0306-4603(84)90056-x.
10
Mecamylamine attenuates cue-induced reinstatement of nicotine-seeking behavior in rats.美加明可减弱线索诱导的大鼠尼古丁觅求行为的恢复。
Neuropsychopharmacology. 2007 Mar;32(3):710-8. doi: 10.1038/sj.npp.1301129. Epub 2006 Jun 21.

引用本文的文献

1
Advances in smoking cessation pharmacotherapy: Non-nicotinic approaches in animal models.戒烟药物治疗的新进展:动物模型中的非尼古丁方法。
Neuropharmacology. 2020 Nov 1;178:108225. doi: 10.1016/j.neuropharm.2020.108225. Epub 2020 Aug 3.
2
More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder.不止是烟和贴片:探寻治疗烟草使用障碍的药物疗法。
Pharmacol Rev. 2020 Apr;72(2):527-557. doi: 10.1124/pr.119.018028.
3
Targeting the 42- and 7-Subtypes of Nicotinic Acetylcholine Receptors for Smoking Cessation Medication Development.
靶向烟碱型乙酰胆碱受体的42亚型和7亚型用于戒烟药物开发。
J Addict Res Ther. 2019;10(2). Epub 2019 Apr 15.
4
Green tobacco sickness: mecamylamine, varenicline, and nicotine vaccine as clinical research tools and potential therapeutics.绿烟病:美金刚、伐尼克兰和尼古丁疫苗作为临床研究工具和潜在治疗药物。
Expert Rev Clin Pharmacol. 2019 Mar;12(3):189-195. doi: 10.1080/17512433.2019.1570844. Epub 2019 Jan 24.
5
Mutually augmenting interactions of dextromethorphan and sazetidine-A for reducing nicotine self-administration in rats.右美沙芬和赛洛啡因相互增强作用,减少大鼠尼古丁自我给药。
Pharmacol Biochem Behav. 2018 Mar;166:42-47. doi: 10.1016/j.pbb.2018.01.005. Epub 2018 Jan 31.
6
Altered nicotine reward-associated behavior following α4 nAChR subunit deletion in ventral midbrain.腹侧中脑α4烟碱型乙酰胆碱受体亚基缺失后与尼古丁奖赏相关的行为改变。
PLoS One. 2017 Jul 31;12(7):e0182142. doi: 10.1371/journal.pone.0182142. eCollection 2017.
7
Nicotinic Acetylcholine Receptor (nAChR) Dependent Chorda Tympani Taste Nerve Responses to Nicotine, Ethanol and Acetylcholine.烟碱型乙酰胆碱受体(nAChR)依赖的鼓索味觉神经对尼古丁、乙醇和乙酰胆碱的反应。
PLoS One. 2015 Jun 3;10(6):e0127936. doi: 10.1371/journal.pone.0127936. eCollection 2015.
8
Diverse strategies targeting α7 homomeric and α6β2* heteromeric nicotinic acetylcholine receptors for smoking cessation.针对戒烟的 α7 同型和 α6β2*异源型烟碱型乙酰胆碱受体的多种策略。
Ann N Y Acad Sci. 2014 Oct;1327(1):27-45. doi: 10.1111/nyas.12421. Epub 2014 Apr 14.
9
Marshaling the evidence for greater regulation and control of tobacco products: A call for action.为加强烟草产品监管和控制而整合证据:行动呼吁。
Ann Behav Med. 1995 Mar;17(1):3-14. doi: 10.1007/BF02888801.
10
Translating laboratory discovery to the clinic: from nicotine and mecamylamine to Tourette's, depression, and beyond.将实验室发现转化为临床应用:从尼古丁和美加仑胺到妥瑞氏症、抑郁症等。
Physiol Behav. 2012 Dec 5;107(5):801-8. doi: 10.1016/j.physbeh.2012.06.023. Epub 2012 Jul 6.